
PMV Pharmaceuticals PMVP
$ 1.78
2.29%
Country |
|
IPO year |
2020 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
52.5 M |
Market Cap[1] |
$ 93.5 M |
EBITDA (LTM) |
$ -86.1 M |
P/E (LTM) |
-0.871622 |
P/S (LTM) |
- |
EPS (LTM) |
-1.48 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
vTv Therapeutics
VTVT
|
$ 30.33 | 0.59 % | $ 120 M | Nasdaq Global Select Market | ||
|
Voyager Therapeutics
VYGR
|
$ 2.46 | 0.41 % | $ 144 M | Nasdaq Global Select Market | ||
|
Wave Life Sciences Ltd.
WVE
|
$ 3.75 | 0.66 % | $ 632 M | Nasdaq Global Select Market | ||
|
Xenetic Biosciences
XBIO
|
$ 2.2 | 0.45 % | $ 3.74 M | Nasdaq Capital Market | ||
|
XBiotech
XBIT
|
$ 2.18 | 0.23 % | $ 66.5 M | Nasdaq Global Select Market | ||
|
Exicure
XCUR
|
$ 1.07 | 3.48 % | $ 6.74 M | Nasdaq Capital Market | ||
|
Xenon Pharmaceuticals
XENE
|
$ 37.57 | 4.68 % | $ 2.98 B | Nasdaq Global Select Market | ||
|
Xeris Pharmaceuticals
XERS
|
$ 10.13 | 11.56 % | $ 1.63 B | Nasdaq Global Select Market | ||
|
X4 Pharmaceuticals
XFOR
|
$ 2.9 | 2.47 % | $ 123 M | Nasdaq Capital Market | ||
|
Xencor
XNCR
|
$ 25.63 | 3.18 % | $ 1.9 B | Nasdaq Global Select Market,SPB | ||
|
22nd Century Group
XXII
|
$ 0.91 | 2.13 % | $ 168 K | NYSE American | ||
|
Zai Lab Limited
ZLAB
|
$ 25.62 | 5.3 % | $ 28.1 B | Nasdaq Global Select Market | ||
|
Zentalis Pharmaceuticals
ZNTL
|
$ 2.78 | 10.32 % | $ 200 M | Nasdaq Global Market | ||
|
Zoetis
ZTS
|
$ 71.41 | 2.45 % | $ 31.7 B | NYSE,SPB | ||
|
Alterity Therapeutics Limited
ATHE
|
$ 3.22 | 1.09 % | $ 20.6 B | Nasdaq Capital Market | ||
|
Dr. Reddy's Laboratories Limited
RDY
|
$ 12.32 | 0.57 % | $ 10.3 B | NYSE | ||
|
Mirati Therapeutics
MRTX
|
- | - | $ 3.3 B | Nasdaq Global Select Market,SPB | ||
|
Gritstone Oncology
GRTS
|
- | 0.42 % | $ 213 M | Nasdaq Global Select Market | ||
|
NexImmune
NEXI
|
- | 70.13 % | $ 4.12 M | Nasdaq Global Market | ||
|
Harpoon Therapeutics
HARP
|
- | - | $ 763 M | Nasdaq Global Select Market | ||
|
InVivo Therapeutics Holdings Corp.
NVIV
|
- | -37.48 % | $ 476 K | Nasdaq Capital Market | ||
|
Nymox Pharmaceutical Corporation
NYMX
|
- | -19.68 % | $ 18.4 M | Nasdaq Capital Market | ||
|
ObsEva SA
OBSV
|
- | -15.52 % | $ 10.5 M | Nasdaq Global Select Market | ||
|
HOOKIPA Pharma
HOOK
|
- | -6.92 % | $ 79.4 M | Nasdaq Global Select Market | ||
|
Guardion Health Sciences
GHSI
|
- | -0.31 % | $ 3.64 M | Nasdaq Capital Market | ||
|
Opiant Pharmaceuticals
OPNT
|
- | - | $ 109 M | Nasdaq Global Select Market | ||
|
Orchard Therapeutics plc
ORTX
|
- | 1.02 % | $ 90.8 M | Nasdaq Global Select Market | ||
|
La Jolla Pharmaceutical Company
LJPC
|
- | - | $ 154 M | Nasdaq Capital Market | ||
|
Oyster Point Pharma
OYST
|
- | - | $ 300 M | Nasdaq Global Select Market | ||
|
Intercept Pharmaceuticals
ICPT
|
- | - | $ 643 M | Nasdaq Global Select Market,SPB | ||
|
9 Meters Biopharma
NMTR
|
- | -42.97 % | $ 1.05 M | Nasdaq Global Select Market | ||
|
Otonomy
OTIC
|
- | -1.96 % | $ 4.68 M | Nasdaq Global Select Market | ||
|
Chinook Therapeutics
KDNY
|
- | - | $ 2.6 B | Nasdaq Global Select Market | ||
|
Kaleido Biosciences
KLDO
|
- | -3.69 % | $ 12.4 M | Nasdaq Global Select Market | ||
|
Kronos Bio
KRON
|
- | 1.49 % | $ 50.8 M | Nasdaq Global Select Market | ||
|
Landos Biopharma
LABP
|
- | 0.58 % | $ 144 M | Nasdaq Global Market | ||
|
PhaseBio Pharmaceuticals
PHAS
|
- | 7.4 % | $ 6.29 M | Nasdaq Global Market | ||
|
Provention Bio
PRVB
|
- | - | $ 2.37 B | Nasdaq Global Select Market | ||
|
Poseida Therapeutics
PSTX
|
- | - | $ 857 M | Nasdaq Global Select Market | ||
|
PolarityTE
PTE
|
- | -0.82 % | $ 1.78 M | Nasdaq Capital Market | ||
|
Atreca
BCEL
|
- | -11.76 % | $ 5.79 M | Nasdaq Global Select Market | ||
|
Reata Pharmaceuticals
RETA
|
- | - | $ 6.29 B | Nasdaq Global Market,SPB | ||
|
Lumos Pharma
LUMO
|
- | - | $ 35.3 M | Nasdaq Global Select Market | ||
|
Stealth BioTherapeutics Corp
MITO
|
- | - | $ 23.9 M | Nasdaq Global Select Market | ||
|
Satsuma Pharmaceuticals
STSA
|
- | -0.9 % | $ 36.5 M | Nasdaq Global Market | ||
|
89bio
ETNB
|
- | - | $ 1.55 B | Nasdaq Global Market | ||
|
Syros Pharmaceuticals
SYRS
|
- | -8.44 % | $ 3.4 M | Nasdaq Global Select Market | ||
|
SpringWorks Therapeutics
SWTX
|
- | - | $ 3.48 B | Nasdaq Global Select Market,SPB | ||
|
Trevena
TRVN
|
- | -46.58 % | $ 31.8 M | Nasdaq Capital Market | ||
|
Oncorus
ONCR
|
- | -8.54 % | $ 3.19 M | Nasdaq Global Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.